GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures

• Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments
• MIM Symphony HDR Prostate[i] is an impressive new solution that provides visualization of reoriented MRI contours on the live ultrasound during HDR procedures

Dr. Peter Rossi, MD, FABS, Chairman of the Board at the American Brachytherapy Society and Radiation Oncologist at Valley View Hospital, said, “I often get the question, what is the best imaging modality for planning HDR prostate procedures, ultrasound or CT? My response is always MRI. MRI guidance enables more confident, precise treatments and reduces toxicity to organs at risk. I’ve had the pleasure of providing my patients with precise treatments using MRI guidance in MIM Symphony HDR Prostate, and I look forward to other clinics having the same opportunity.”

• Defining the lesion and tracking changes to guide needle placement, even as the prostate moves during the procedure;
• Correcting differences between MRI supine and ultrasound lithotomy orientations with ReSlicer, a tool in MIM Symphony HDR Prostate; and
• Automatically digitizing needles on CT or ultrasound planning images as well as performing needle review and free length checks.

“Our goal with this solution is to empower clinicians to plan and deliver safe, more informed, and precise treatment for patients with prostate disease,” said Andrew Nelson, CEO of MIM Software, GE HealthCare. “MIM Symphony HDR Prostate exemplifies decades of MIM Software and GE HealthCare innovations that enable precision care, and we’re thrilled to expand our impact in brachytherapy.”

• July 10-13: World Congress of Brachytherapy in National Harbor, Maryland, USA
• July 21-25: American Association of Physicists in Medicine Annual Meeting in Los Angeles, California, USA
• September 11-14: European Conference of Medical Physics in Munich, Germany